Stocks Health care HROW
NASDAQ · Health careHarrow, Inc. (HROW)
Harrow, Inc. brought in $275.6M of revenue over the twelve months to June 30, 2026, up 21.1% from a year earlier. It posted a net loss of $37.2M. Operating cash flow minus capital spending left $43M of free cash flow in fiscal 2025. At June 30, 2026 it held $83.9M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 10, 2026.
What Harrow, Inc. does
Harrow, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker HROW.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $272.3M | -$5.1M | -$0.14 | $43M |
| 2024 | $199.6M | -$17.5M | -$0.49 | -$23.8M |
| 2023 | $130.2M | -$24.4M | -$0.75 | $2.4M |
| 2022 | $88.6M | -$14.1M | -$0.51 | -$892K |
| 2021 | $72.5M | -$18M | -$0.69 | $3.3M |
| 2020 | $48.9M | -$3.4M | -$0.13 | -$2M |
Latest SEC filings
What Harrow, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 4, 2026
- August 10, 2026Quarterly report 10-Q · period to June 30, 2026
- August 10, 2026
- August 6, 2026
- July 31, 2026Passive stake changed SCHEDULE 13G/A
- June 22, 2026
- June 3, 2026
- May 11, 2026Quarterly report 10-Q · period to March 31, 2026
- May 11, 2026Passive stake changed SCHEDULE 13G/A
- May 11, 2026
Questions about HROW
What does Harrow, Inc. do?
Harrow, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker HROW.
Is Harrow, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $37.2M on revenue of $275.6M.
How much revenue does Harrow, Inc. make?
Over the twelve months to June 30, 2026 Harrow, Inc. reported revenue of $275.6M. That is 21.1% more than a year earlier.
When did Harrow, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 10, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the executive or director change from September 4, 2026.
Similar companies
Follow HROW
Get an email when Harrow, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow HROW: get an email when it filesWhere the numbers come from
Financial figures are the values Harrow, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.